Surface Pharmaceuticals, Inc. Announces $20 Million Series A Financing From Flying L Partners
Reuters
May 15 (Reuters) – Imprimis Pharmaceuticals Inc:
* SURFACE PHARMACEUTICALS, INC. ANNOUNCES $20 MILLION SERIES A FINANCING FROM FLYING L PARTNERS
* IMPRIMIS PHARMACEUTICALS – SURFACE PHARMA INTENDS TO USE PROCEEDS OF FINANCING TO ADVANCE CLINICAL DEVELOPMENT PROGRAMS FOCUSED ON OCULAR SURFACE DISEASE Source text for Eikon: Further company coverage: